Leuthold Group, LLC Biogen Inc. Transaction History

Leuthold Group, LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$242.95 - $284.63 $2.52 Million - $2.95 Million	-10,358 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$236.26 - $355.63 $1.25 Million - $1.88 Million	-5,280 Reduced 33.76%	10,358 $2.54 Million
Q3 2020 Nov 16, 2020	SELL	$264.77 - $305.71 $214,728 - $247,930	-811 Reduced 4.93%	15,638 $4.44 Million
Q2 2020 Aug 14, 2020	BUY	$258.66 - $342.55 $25,607 - $33,912	99 Added 0.61%	16,449 $4.4 Million
Q1 2020 May 15, 2020	SELL	$268.85 - $341.04 $406,770 - $515,993	-1,513 Reduced 8.47%	16,350 $5.17 Million
Q4 2019 Feb 14, 2020	BUY	$220.06 - $304.07 $3.93 Million - $5.43 Million	17,863 New	17,863 $5.3 Million
Q3 2019 Nov 14, 2019	SELL	$217.44 - $243.88 $3.11 Million - $3.49 Million	-14,291 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$219.29 - $241.72 $169,291 - $186,607	-772 Reduced 5.13%	14,291 $3.34 Million
Q1 2019 May 15, 2019	BUY	$216.71 - $338.96 $1.21 Million - $1.89 Million	5,566 Added 58.61%	15,063 $3.56 Million
Q4 2018 Feb 14, 2019	SELL	$278.5 - $352.75 $167,935 - $212,708	-603 Reduced 5.97%	9,497 $2.86 Million
Q3 2018 Nov 14, 2018	BUY	$293.51 - $383.83 $2.96 Million - $3.88 Million	10,100 New	10,100 $3.57 Million
Q1 2018 May 15, 2018	SELL	$260.13 - $367.91 $6.4 Million - $9.06 Million	-24,619 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$307.64 - $344.58 $1.74 Million - $1.95 Million	5,648 Added 29.77%	24,619 $7.84 Million
Q3 2017 Nov 14, 2017	SELL	$281.15 - $329.69 $25,022 - $29,342	-89 Reduced 0.47%	18,971 $5.94 Million
Q2 2017 Aug 14, 2017	BUY	N/A	19,060	19,060 $5.17 Million

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Leuthold Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Leuthold Group, LLC with notifications on news.